Antidepressant effects of ketamine in depressed patients

Robert M Berman; Angela Cappiello; Amit Anand; Dan A Oren; George R Heninger; Dennis S Charney; John H Krystal

doi:10.1016/s0006-3223(99)00230-9

journal article Feb 01, 2000

Antidepressant effects of ketamine in depressed patients

Robert M Berman Angela Cappiello Amit Anand Dan A Oren George R Heninger Dennis S Charney John H Krystal

Biological Psychiatry Vol. 47 No. 4 pp. 351-354 · Elsevier BV

View at Publisher Save 10.1016/s0006-3223(99)00230-9

Topics

No keywords indexed for this article. Browse by subject →

References

25

[1]

Boyer "Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study" J Mol Neurosci (1998) 10.1007/bf02761776

[2]

Crane "Cycloserine as an antidepressant agent" Am J Psychiatry (1959) 10.1176/ajp.115.11.1025

[3]

Crane "The psychotropic effects of Cycloserine" Compr Psychiatry (1961) 10.1016/s0010-440x(61)80007-2

[4]

Domino "Pharmacologic effects of CI-581, a new dissociative anesthetic, in man" Clin Pharmacol Ther (1965) 10.1002/cpt196563279

[5]

Eide "Ketamine" Pain (1997) 10.1097/00006396-199708000-00042

[6]

Elliot "N-Methyl-D-Aspartate (NMDA) receptors, μ and κ opioid tolerance, and perspective on new analgesic drug development" Neuropsychopharmacology (1995) 10.1016/0893-133x(95)00083-p

[7]

First (1997)

[8]

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans

John H. Krystal

Archives of General Psychiatry 1994 10.1001/archpsyc.1994.03950030035004

[9]

Layer "Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)" Pharmacol Biochem Behav (1995) 10.1016/0091-3057(95)00155-p

[10]

Lindefors "Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex" Brain Res (1997) 10.1016/s0006-8993(97)00255-2

[11]

Malhotra "Loading dose imipramine—new approach to pharmacotherapy of melancholic depression" J Psychiatric Res (1996) 10.1016/0022-3956(95)00042-9

[12]

Meloni "Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats" Pharmacol Biochem Behav (1993) 10.1016/0091-3057(93)90374-3

[13]

Mjellem "Reduction of NMDA-induced behavior after acute and chronic administration of desipramine in mice" Neuropharmacology (1993) 10.1016/0028-3908(93)90055-8

[14]

Moryl "Potential antidepressive properties of amantadine, memantine and bifemelane" Pharmacol Toxicol (1993) 10.1111/j.1600-0773.1993.tb01351.x

[15]

Panconi "MK-801 and enantiomers" Pharmacol, Biochem Behav (1993) 10.1016/0091-3057(93)90310-p

[16]

Papp "Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression" Eur J Pharmacol (1994) 10.1016/0014-2999(94)90516-9

[17]

Papp "Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression" Eur J Pharmacol (1996) 10.1016/s0014-2999(96)00675-9

[18]

Paul "Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments" J Pharmacol Exp Ther (1994)

[19]

Pollock "Acute antidepressant effect following pulse loading with intravenous and oral clomipramine" Arch Gen Psychiatry (1989) 10.1001/archpsyc.1989.01810010031005

[20]

Przegalinski "Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist" Neuropharmacology (1997) 10.1016/s0028-3908(96)00157-8

[21]

Sallee "Pulse intravenous clomipramine for depressed adolescents" Am J Psychiatry (1997) 10.1176/ajp.154.5.668

[22]

Skolnick "Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment" Pharmacopsychiatry (1996) 10.1055/s-2007-979537

[23]

Trullas "Functional antagonists at the NMDA receptor complex exhibit antidepressant actions" Eur J Pharmacol (1990) 10.1016/0014-2999(90)90204-j

[24]

Vale "Amantadine in depression" Lancet (1971) 10.1016/s0140-6736(71)90153-x

[25]

Wong "Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats" Eur J Pharmacol (1996) 10.1016/0014-2999(95)00728-8

Cited By

3,290

Targeted silencing of hippocampal TNF-α via siRNA nanoplexes to alleviate depression

Regina Martuscello, Robert N. Spengler · 2026

NeuroImmune Pharmacology and Therap...

Comparative effectiveness and safety of esketamine versus injectable racemic ketamine and oral antidepressants for major depressive disorder: A population-based target trial emulation

Ching-Hua Julie Lee, Yunzhe Qian · 2026

Journal of Affective Disorders

Similar destabilization of neural dynamics under different general anesthetics

Adam J. Eisen, Alexandra G. Bardon · 2026

Cell Reports

Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications

Francesco Weiss, Anna Magnesa · 2025

Brain Sciences

Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models

Claudio Agnorelli, Meg Spriggs · 2025

Neuroscience & Biobehavioral Re...

The diverse effects of ketamine, jack-of-all-trades: a narrative review

Nicholas D. Richards, Simon J. Howell · 2025

British Journal of Anaesthesia

Enhanced ERK activity extends ketamine’s antidepressant effects by augmenting synaptic plasticity

Z. Zack Ma, Natalie J. Guzikowski · 2025

Science

Antidepressant efficacy of ketamine plus naltrexone for major depression comorbid with alcohol use disorder: a randomized controlled trial

Gihyun Yoon, Brian Pittman · 2025

The International Journal of Neurop...

The Impact of Intraoperative Ketamine on Postoperative Depression and Anxiety in Patients with Preexisting Depression and Anxiety Undergoing Total Hip Arthroplasty

Tegshjargal Baasansukh, Syed Fahad Gillani · 2025

medtigo Journal of Medicine

Ketamine and Esketamine in Clinical Trials: FDA‐Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations

Ksenia A. Vekhova, Eugenia D. Namiot · 2024

Clinical Pharmacology & Therape...

RETRACTED ARTICLE: ArticleNoteRapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial

Ahmad Zolghadriha, Afagh Anjomshoaa · 2024

BMC Psychiatry

Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine

Miroslav Adzic, Iva Lukic · 2023

Life Sciences

Classical and non-classical psychedelic drugs induce common network changes in human cortex

Rui Dai, Tony E. Larkin · 2023

NeuroImage

Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry

Jacob S. Aday, Brian S. Barnett · 2023

Psychedelic Medicine

Psychedelics and Neural Plasticity: Therapeutic Implications

Steven F. Grieco, Eero Castrén · 2022

The Journal of Neuroscience

Long-term safety of ketamine and esketamine in treatment of depression

Sina Nikayin, Eva Murphy · 2022

Expert Opinion on Drug Safety

Antidepressant and Antipsychotic Drugs Reduce Viral Infection by SARS-CoV-2 and Fluoxetine Shows Antiviral Activity Against the Novel Variants in vitro

Senem Merve Fred, Suvi Kuivanen · 2022

Frontiers in Pharmacology

Sex-Specific Transcriptomic Signatures in Brain Regions Critical for Neuropathic Pain-Induced Depression

Weiping Dai, Shuying Huang · 2022

Frontiers in Molecular Neuroscience

The Future of Training and Practice in Neuromodulation: An Interventional Psychiatry Perspective

Nicholas T. Trapp, Nolan R. Williams · 2021

Frontiers in Psychiatry

A wake-up call: Sleep physiology and related translational discrepancies in studies of rapid-acting antidepressants

Okko Alitalo, Roosa Saarreharju · 2021

Progress in Neurobiology

Metrics

3,290

Citations

25

References

Details

Published: Feb 01, 2000
Vol/Issue: 47(4)
Pages: 351-354
License: View

Authors

Cite This Article

Robert M Berman, Angela Cappiello, Amit Anand, et al. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351-354. https://doi.org/10.1016/s0006-3223(99)00230-9

Antidepressant effects of ketamine in depressed patients

You May Also Like